Timo Rath | Financial Data Analysis | Best Researcher Award

Assoc Prof Dr. Timo Rath | Financial Data Analysis | Best Researcher Award

University Hospital Erlangen | Germany

Author Profile

Scopus

👨‍⚕️ Summary

Dr. Timo Rath, M.D., MHBA, is a board-certified internist and gastroenterologist with a specialization in advanced endoscopic techniques and inflammatory bowel diseases (IBD). Currently serving as Professor of Endoscopy and Consultant at the University Hospital Erlangen, Germany, he combines clinical excellence with innovative research. With over 115 peer-reviewed publications and contributions to national and international clinical guidelines, Dr. Rath is recognized as a leading figure in modern gastroenterology.

🎓 Education

Dr. Rath studied medicine from 2000 to 2007 at Philipps-University Marburg, RWTH Aachen, and LECOM (USA). He passed his final medical exam in 2007 with distinction (1.66) and earned his M.D. degree with summa cum laude for his thesis on matrix metalloproteinases in gastrointestinal lesions. He later received his Venia Legendi (habilitation) in 2018 and holds a Master of Health Business Administration (MHBA).

🏥 Professional Experience

After completing his residency in internal medicine and gastroenterology at the University Hospitals of Gießen and Erlangen, Dr. Rath completed a research fellowship at Harvard Medical School, Brigham and Women’s Hospital. Since 2017, he has served as Professor of Endoscopy and Consultant at the Ludwig Demling Endoscopy Center, Erlangen.

📊 Academic Impact

Dr. Rath has authored or co-authored over 115 peer-reviewed articles, totaling more than 3,200 citations with an h-index of 32. He has delivered over 100 invited talks at national and international conferences. He serves on editorial boards of Gastrointestinal Endoscopy and World Journal of Gastroenterology, and is a frequent reviewer for top journals such as Lancet Gastroenterology & Hepatology, Gastroenterology, and Endoscopy.

🛠️ Technical Skills

Dr. Rath’s clinical expertise includes advanced endoscopic procedures such as EMR (endoscopic mucosal resection), ESD (submucosal dissection), and FTR (full-thickness resection). He is also a leader in molecular imaging, AI-assisted endoscopy, and the endoscopic treatment of perforations, GI leaks, and fistulae.

👨‍🏫 Teaching Experience

He is actively involved in medical education, training medical students, residents, and fellows in gastroenterology and endoscopy. Dr. Rath also mentors clinician-scientists and contributes to international workshops, training courses, and academic symposia.

🔬 Research Interests

Dr. Rath’s research focuses on IBD-related imaging, mucosal healing, intestinal permeability, and the use of artificial intelligence in diagnostic endoscopy. He is engaged in the development of clinical guidelines and pursues translational research in gastrointestinal immunology and personalized medicine.

📖Publications

A Novel Switching of Artificial Intelligence to Generate Simultaneously Multimodal Images to Assess Inflammation and Predict Outcomes in Ulcerative Colitis—(With Video)

  • Year: 2025
A computer-aided detection system in the everyday setting of diagnostic, screening, and surveillance colonoscopy: An international, randomized trial
  • Year: 2024
NLRP3 Inhibition Leads to Impaired Mucosal Fibroblast Function in Patients with Inflammatory Bowel Diseases
  • Year: 2024
Intestinal Barrier Healing Is Superior to Endoscopic and Histologic Remission for Predicting Major Adverse Outcomes in Inflammatory Bowel Disease: The Prospective ERIca Trial
  • Year: 2024
Reverse switching from the biosimilar SB2 to the originator infliximab in previously switched patients with inflammatory bowel diseases: results of a prospective long-term cohort study
  • Year: 2024

 

Wenbin Zhang | Educational Data Analysis | Best Researcher Award

Prof. Wenbin Zhang | Educational Data Analysis | Best Researcher Award

Sir Run Run Shaw Hospital, Zhejiang University School of Medicine | China

Publication Profile

Orcid

Summary 📝

Dr. Wenbin Zhang is a Professor and Chief Physician at Sir Run Run Shaw Hospital, Zhejiang University School of Medicine. With extensive experience in cardiology, he specializes in interventional diagnosis and treatment of complex coronary heart disease, refractory hypertension, and heart failure. His research focuses on hypertension-related myocardial remodeling and the inflammatory mechanisms of atherosclerosis, contributing significantly to the understanding of cardiovascular diseases.

Education 🎓

Dr. Zhang completed his medical education and training at Zhejiang University School of Medicine, where he later became a professor and doctoral supervisor. He continues to shape future medical professionals through his commitment to education and research.

Professional Experience 💼

Dr. Zhang serves as a chief physician and teacher in the cardiology department, focusing on critical illnesses. He is an expert in the management of cardiovascular conditions, including coronary heart disease and heart failure. His professional journey also includes leadership roles in medical education and reforms in clinical practice.

Academic Citations 📚

With nearly 70 journal publications in high-impact medical journals such as SCI and Scopus, Dr. Zhang’s research has made notable contributions to the field of cardiology. His work on myocardial remodeling and atherosclerosis has been widely recognized within the scientific community.

Technical Skills 🛠️

Dr. Zhang is highly skilled in interventional cardiology, including coronary angioplasty and the treatment of refractory hypertension. His expertise also extends to molecular biology techniques, providing critical insights into cardiovascular disease mechanisms.

Teaching Experience 👨‍🏫

As a medical professor, Dr. Zhang is deeply involved in curriculum development and the reform of medical education. He actively integrates innovative teaching methods to improve students’ clinical skills and academic performance, ensuring they are well-prepared for the challenges of modern medicine.

Research Interests 🔬

Dr. Zhang’s primary research interests include the molecular mechanisms of hypertension-related myocardial remodeling and the inflammatory pathways that drive atherosclerosis. His work is paving the way for future therapeutic strategies in cardiovascular disease management.

Top Notes Publications 📚

Variability in Plasma Lipids Between Intensive Statin Therapy and Conventional-Dose Statins Combined with Ezetimibe Therapy in Patients with Coronary Atherosclerosis Disease
    • Authors: Jinhua Jin, Liwen Shan, Manjun Wang, Lu Liu, Tian Xu, Duanbin Li, Zhezhe Chen, Xianglan Liu, Wenbin Zhang, Ya Li

    • Journal: International Heart Journal

    • Year: 2023

Liver enzymes mediate the association between aldehydes co-exposure and hypertriglyceridemia
    • Authors: Duanbin Li, Zhezhe Chen, Yu Shan, Tianli Hu, Xulin Hong, Jun Zhu, Yunhui Zhu, Guosheng Fu, Min Wang, Wenbin Zhang

    • Journal: Ecotoxicology and Environmental Safety

    • Year: 2023

Polydopamine (PDA) coatings with endothelial vascular growth factor (VEGF) immobilization inhibiting neointimal formation post zinc (zn) wire implantation in rat aortas
    • Authors: Jiayin Fu, Qiongjun Zhu, Zhezhe Chen, Jing Zhao, Shaofei Wu, Meng Zhao, Shihui Xu, Dongwu Lai, Guosheng Fu, Wenbin Zhang

    • Journal: Biomaterials Research

    • Year: 2023

Erythrocyte parameters, anemia conditions, and sex differences are associated with the incidence of contrast-associated acute kidney injury after coronary angiography
    • Authors: Xihong Li, Qingqing Chen, Xinrui Yang, Duanbin Li, Changqing Du, Jun Zhang, Wenbin Zhang

    • Journal: Frontiers in Cardiovascular Medicine

    • Year: 2023

Biomimetic and NOS‐Responsive Nanomotor Deeply Delivery a Combination of MSC‐EV and Mitochondrial ROS Scavenger and Promote Heart Repair and Regeneration
    • Authors: Ning Zhang, Mengkang Fan, Yongchao Zhao, Xiaolong Hu, Qiongjun Zhu, Xiaolu Jiao, Qingbo Lv, Duanbin Li, Zheyong Huang, Guosheng Fu, et al.

    • Journal: Advanced Science

    • Year: 2023